Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation

被引：0
|
作者：
Dhanashree Ratra
Krishnakanta Roy
Sneha Giridhar
Sushant Madaan
机构：
[1] Medical Research Foundation,Department of Vitreoretinal Diseases
[2] Sankara Nethralaya,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Anti VEGF; Biosimilar; Comparison with bevacizumab; DME; nAMD; Ranibizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：135 / 149
页数：14
相关论文
共 50 条
  • [1] Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
    Ratra, Dhanashree
    Roy, Krishnakanta
    Giridhar, Sneha
    Madaan, Sushant
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (01) : 135 - 149
  • [2] Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
    Soman, Manoj
    Nair, Indu
    Sheth, Jay U.
    Nair, Unnikrishnan
    OPHTHALMOLOGY AND THERAPY, 2022, 11 (03) : 1175 - 1186
  • [3] Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
    Manoj Soman
    Indu Nair
    Jay U. Sheth
    Unnikrishnan Nair
    Ophthalmology and Therapy, 2022, 11 : 1175 - 1186
  • [4] Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data
    Ashish Sharma
    M. Hafeez Faridi
    Nilesh Kumar
    Nikulaa Parachuri
    Rohini Sharma
    Baruch D. Kuppermann
    Francesco Bandello
    Anat Loewenstein
    Carl D. Regillo
    Eye, 2020, 34 : 1008 - 1009
  • [5] Immunogenicity and efficacy after switching from original Ranibizumab to a Ranibizumab biosimilar: real-world data
    Sharma, Ashish
    Hafeez Faridi, M.
    Kumar, Nilesh
    Parachuri, Nikulaa
    Sharma, Rohini
    Kuppermann, Baruch D.
    Bandello, Francesco
    Loewenstein, Anat
    Regillo, Carl D.
    EYE, 2020, 34 (06) : 1008 - 1009
  • [6] Biosimilar versus InnovAtor MoLecule of RAnibizumab in Neovascular Age-Related MaCular DEgeneration (The BALANCE Trial) : Real-World Evidence
    Chakraborty, Debdulal
    Mondal, Soumen
    Boral, Subhendu
    Das, Arnab
    Sinha, Tushar Kanti
    Majumdar, Saptorshi
    Bhattacharya, Ranabir
    Maitra, Ritobroto
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1067 - 1076
  • [7] Biosimilar Ranibizumab and Innovator Ranibizumab-Immunogenicity Assessment and Its Impact on Safety and Efficacy
    Sharma, Ashish
    Kumar, Nilesh
    Kuppermann, Baruch D.
    JAMA OPHTHALMOLOGY, 2023, 141 (02) : 128 - 129
  • [8] Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema
    Koc, Irem
    Kadayifcilar, Sibel
    Eldem, Bora
    OPHTHALMOLOGICA, 2018, 239 (2-3) : 85 - 93
  • [9] Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
    Debdulal Chakraborty
    Michael W. Stewart
    Jay U. Sheth
    Tushar K. Sinha
    Subhendu Boral
    Arnab Das
    Soumen Mondal
    Angshuman Mukherjee
    Ophthalmology and Therapy, 2021, 10 : 337 - 348
  • [10] Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
    Chakraborty, Debdulal
    Stewart, Michael W.
    Sheth, Jay U.
    Sinha, Tushar K.
    Boral, Subhendu
    Das, Arnab
    Mondal, Soumen
    Mukherjee, Angshuman
    OPHTHALMOLOGY AND THERAPY, 2021, 10 (02) : 337 - 348
12345